Under Trump Administration, Pfizer Doubled Profits

WASHINGTON – In the midst of this week’s flood of Big Pharma third-quarter earnings reports, Pfizer, the country’s largest drug maker, announced a striking increase in profits. The company reportedly raked in $7.68 billion this quarter, nearly doubling its profits. Restore Public Trust released the following statement in response:

“President Trump and Alex Azar invited Big Pharma into the administration, and drug companies are seeing the results: huge paydays,” said Lizzy Price, director of Restore Public Trust. “The Trump administration has given in time and time again to their buddies at Big Pharma, and now drug companies like Pfizer are lining their pockets with fat checks as sick Americans foot the bill. It’s time the nation’s health department started valuing Americans’ health over industry profits.”

Pfizer is just one of the 19 pharmaceutical companies and lobbying groups with significant ties to the Trump administration. Learn more about these connections at BigPharmasBestFriends.org.

# # #

Press Release

Big PharmaPress Release

Comments are disabled.